MBL77 Options
Not all individuals with CLL require therapy. In spite of all modern advancements, the iwCLL continue to suggests watchful observation for sufferers with asymptomatic illness.86 This advice is predicated on at least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,